 LOS ALTOS, Calif., Dec. 29, 2022 GLOBE NEWSWIRE Unicycive Therapeutics, Inc. Nasdaq: UNCY, a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced the termination of its at-the-market equity offering program the ATM Offering with JonesTrading Institutional Services, LLC as sales agent. The Company elected to terminate the ATM Offering to limit ... The post Unicycive Announces Termination of At-The-Market Offering of Shares of Co... 